Given that fatty acid synthesis and oxidation can negatively regulate each other, this poses an intriguing question as to how the ovarian cancer cells are able to overcome the regulatory effects of malonyl CoA, a substrate for fatty acid synthesis and an allosteric inhibitor of CPT1A. The gene discussed is CPT1A; the disease is ovarian cancer.